ViewPoint Therapeutics

ViewPoint Therapeutics is a biotechnology company dedicated to developing treatments for protein misfolding diseases, including cataracts. The company's crystallin stabilizers include a small molecule that functions in preclinical models of age-related cataracts through target-based screening and optimization efforts, providing physicians with drugs to prevent or reverse protein misfolding, which is associated with many common age-related conditions, including cataracts, presbyopia, and neurodegenerative diseases.